Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

VTI vs ITOT: Low-Cost Total Market ETFs Face Tech-Heavy Risk
Markets Daniel Marsh

VTI vs ITOT: Low-Cost Total Market ETFs Face Tech-Heavy Risk

VTI and ITOT, two low-cost total market ETFs, saw inflows on May 7 as U.S. equity funds attracted $5.83B. Both remain heavily weighted toward big tech, raising concentration risk.

VTI VOO NVDA AAPL GOOGL MSFT AMZN
IREN Shares Slide on $2 Billion Convertible Note Plan After Nvidia Deal
Markets Daniel Marsh

IREN Shares Slide on $2 Billion Convertible Note Plan After Nvidia Deal

IREN Ltd. shares dropped 9.43% to $55.43 premarket Monday after announcing a $2 billion convertible note offering, following last week's Nvidia partnership. The company's Q3 revenue fell to $144.8 million with a net loss of $247.8 million.

IREN NVDA MSFT
Markets Daniel Marsh

Nike Stock: Institutional Buying vs. Rising Short Interest

Nicholas Company reported a 123,652-share Nike stake worth $6.53 million as of March 31, while short interest rose to 4.67% by May 1. Wells Fargo downgraded Nike, citing GLP-1 drug risks.

NKE
Helport AI Shares Skyrocket 49% in Premarket on Heavy Volume
Markets Daniel Marsh

Helport AI Shares Skyrocket 49% in Premarket on Heavy Volume

Helport AI shares jumped 49.1% to $1.47 in U.S. premarket trading Monday, with volume surging to 6.98 million shares. No new corporate news was released.

HPAI
Soluna Holdings Gains SEC Nod for Share Resale Registration
Markets Daniel Marsh

Soluna Holdings Gains SEC Nod for Share Resale Registration

Soluna Holdings secures SEC clearance for a resale registration of 2.4M shares, while advancing its renewable energy and bitcoin hosting projects.

SLNH
Novo Nordisk Stock Climbs as Ozempic Study Shows 15.4% Weight Loss in Seniors
Markets Daniel Marsh

Novo Nordisk Stock Climbs as Ozempic Study Shows 15.4% Weight Loss in Seniors

Novo Nordisk B shares gained 3.75% in Copenhagen after a pooled analysis revealed semaglutide 2.4 mg resulted in 15.4% weight loss in older adults, reinforcing the company's obesity portfolio.

NVO LLY
POET Technologies Hit by Lawsuit After Marvell Cancels Celestial AI Orders
Markets Daniel Marsh

POET Technologies Hit by Lawsuit After Marvell Cancels Celestial AI Orders

POET Technologies faces a securities class action after Marvell canceled Celestial AI orders, causing a 45% stock drop. Lead-plaintiff deadline is June 29.

POET MRVL AVGO
Oil Spike Tests Wall Street Rally as Futures Hold Steady
Markets Daniel Marsh

Oil Spike Tests Wall Street Rally as Futures Hold Steady

U.S. stock futures were flat early Monday as a 2.3% spike in oil prices to $97.64 a barrel tested the recent record rally, with airlines falling and Fed rate-cut expectations pushed back.

LUV UAL DAL AAL MU INTC AMD NVDA TSLA MSFT USO
Sandisk Hits Record High as AI Storage Demand Drives $245B Market Cap
Markets Daniel Marsh

Sandisk Hits Record High as AI Storage Demand Drives $245B Market Cap

Sandisk shares hit an all-time high of $1,562.34, pushing its market cap to $245 billion as AI data-center demand fuels a 251% revenue surge.

SNDK WDC MU
Australian Shares Tumble on US-Iran Tensions, CSL Plunges 18%
Markets Daniel Marsh

Australian Shares Tumble on US-Iran Tensions, CSL Plunges 18%

Australian shares opened lower as US-Iran tensions escalate and CSL's 18% plunge drags healthcare down 8%. Energy stocks provide the only bright spot.

CSL ASX SAN MET DYN
Fluence Energy Surges 27% on AI Data Center Deals, Record Backlog
Markets Daniel Marsh

Fluence Energy Surges 27% on AI Data Center Deals, Record Backlog

Fluence Energy stock soared 27.4% Friday after announcing master supply agreements with two major data-center clients and a record $5.6 billion backlog, despite a quarterly revenue miss.

FLNC
ARK Buys CoreWeave Dip; Wells Fargo Lifts Target on $99B Backlog
Markets Daniel Marsh

ARK Buys CoreWeave Dip; Wells Fargo Lifts Target on $99B Backlog

ARK funds purchased 113,076 CoreWeave shares for $12.9M after the stock fell 11% on weak guidance. Wells Fargo raised its price target to $155, focusing on the company's $99.4B backlog.

CRWV ARKK ARKQ META NVDA